You are in:Home/Publications/Alpha-2-Macroglobulin in Saliva as a Noninvasive Glycemic Control Marker in Type 2 Diabetes Mellitus Patient

Dr. amira kamal eldin mohammed elalfy :: Publications:

Title:
Alpha-2-Macroglobulin in Saliva as a Noninvasive Glycemic Control Marker in Type 2 Diabetes Mellitus Patient
Authors: Amira K. El-Alfy, Medhat A. Khalil
Year: 2022
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper amira kamal eldin mohammed elalfy_Amira.pdf
Supplementary materials Not Available
Abstract:

ne-modulating capabilities have been discovered for the multifunctional steroid hormone known as vitamin D. Vitamin D deficiency was found to be linked with advancement of Chronic liver disease (CLD) as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), as well as the hepatitis C virus (HCV). Objective: The aim of the current work was to investigate the association between vitamin D deficiency and HCC in patients with liver cirrhosis. Patients and Methods: Ninety individuals with liver cirrhosis (LC) participated in this trial. The included subjects were divided into two groups; Group A consisted of 45 cirrhotic patients without HCC, and Group B consisted of 45 cirrhotic patients with HCC. Results: Liver function tests: INR, ALT, AST, total bilirubin were all statistically substantially higher in group B than in group A (P=0.001, 0.001, 0.001, and 0.011, respectively). However, group B's serum albumin and platelet count were considerably lower than group A's (P=0.003 and 0.001, respectively) compared to each other. In comparison to group A's alphafetoprotein (AFP) of 8.69±1.84, group B's AFP of 254.33±32.69 was statistically substantially higher (P = 0.001).Vitamin D levels in group B were substantially lower (19.33±4.68) than in group A (26.31±4.95) (P= 0.00). With an area under the curve (AUC) of 0.802, vitamin D

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus